期刊文献+

应用两性霉素B治疗ICU念珠菌感染临床观察 被引量:1

下载PDF
导出
摘要 目的评价近年来静脉应用两性霉素B治疗念珠菌感染的疗效及不良反应。方法回顾性分析40例念珠菌感染患者静脉应用两性霉素B的疗效、治疗过程中的不良反应及相应防治措施。结果除1例因不良反应明显而中途停药外,其余39例患者病原学监测真菌均已清除。应用两性霉素B治疗过程中,低钾血症的发生率最高(80.0%),肾功能损害、血红蛋白下降、血小板下降、寒战、心电图改变、肝功能损害的发生率分别为32.5%、20.0%、5.0%、17.5%、17.5%、10.0%。结论两性霉素B疗效显著,虽然应用过程中不良反应发生率较高,但只要密切监测病情变化,采取相关措施,仍可用于念珠菌感染的治疗。
出处 《中国医师进修杂志(内科版)》 2007年第6期57-59,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献8

  • 1侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:863
  • 2Eriksson U, Seifert B, Schaffner A. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours:randomisod controlled trial. BMJ,2001,322(7286) :579 -584.
  • 3Goldman RD, Koren G. Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol, 2004,26 ( 7 ) :421 - 426.
  • 4朱利平,汪泽明,石尧忠,潘孝彰,翁心华.静脉应用两性霉素B治疗隐球菌性脑膜炎的不良反应及其防治[J].中国抗感染化疗杂志,2002,2(2):95-97. 被引量:34
  • 5Canada TW, Weavind LM, Augustin KM. Possible liposomal amphotericin B - induced nephrogenic diabetes insipidus. Ann Pharmacother,2003,37( 1 ) :70 -73.
  • 6毕丽岩,万献尧.胰头癌术后 反复寒战高热[J].医师进修杂志,2003,26(1):51-52. 被引量:1
  • 7Cleary JD,Hayman J,Sherwood J,et al. Amphotericin B overdose in pediatric patients with associated cardiac arrest. Ann Phannacother, 1993,27(6) :715 -719.
  • 8Tollemar J, Andersson S, Ringden O, et al. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients. Mycoses, 1992,35(9 - 10) :215 -220.

二级参考文献14

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2石尧忠.隐球菌性脑膜炎的治疗[J].新药与临床,1996,15(5):306-308. 被引量:12
  • 3Sarosi GA. Amphotericin B:still the ‘gold standard' for antifungal therapy[J]. Postgrad Med, 1990, 88: 151-152, 155-156, 165-166
  • 4Grasela TH Jr, Goodwin SD, Walawander MK, et al. Prospective surveillance of intravenous amphotericin B use patterns[J]. Pharmacotherapy, 1990,10: 341-348
  • 5Pathak A, Pien FD, Carvalho L. Amphotericin B use in a community hospital, with special emphasis on side effects[J]. Clin Infect Dis,1998, 26: 334-338
  • 6Luber AD, Maa L, Lam M, et al. Risk factors for amphotericin B-induced nephrotoxicity[J]. J Antimicrob Chemoth,1999, 43: 267-271
  • 7Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709.
  • 8Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
  • 9Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240.
  • 10Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189.

共引文献895

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部